High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.

Narasaraju, Teluguakula; Ravi, Yazhini; Jonsson, Colleen B; Chow, Vincent T K

Narasaraju, Teluguakula; Ravi, Yazhini; Jonsson, Colleen B; Chow, Vincent T K.

Afiliação

Narasaraju T; Regional Biocontainment Laboratory, University of Tennessee Health Science Center, Memphis, TN 38163, USA. Electronic address: ntelugua@uthsc.edu.
Ravi Y; Department of Surgery, University of Connecticut Health, Farmington, CT, USA.
Jonsson CB; Regional Biocontainment Laboratory, University of Tennessee Health Science Center, Memphis, TN 38163, USA.
Chow VTK; Infectious Diseases Translational Research Program, Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, National University Health System, Singapore.

Lancet ; 403(10434): 1338-1339, 2024 Apr 06.

Article em En | MEDLINE | ID: mdl-38582562

Assuntos

COVID-19; Humanos; Corticosteroides/uso terapêutico; SARS-CoV-2

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Limite: Humans Idioma: En Revista: Lancet Ano de publicação: 2024 Tipo de documento: Article País de publicação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google